Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjarne Robberstad

Showing results (91-100 of 91) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 91 results.
The Lancet. Infectious Diseases|December 24, 2024
Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trialRichard Idro, Thandile Nkosi-Gondwe, Robert Opoka, et al.
Pageof 10

Showing results (91-100 of 91) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 91 results.
The Lancet. Infectious Diseases|December 24, 2024
Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trialRichard Idro, Thandile Nkosi-Gondwe, Robert Opoka, et al.
Pageof 10